Subjects will receive two 5mg tablets of Montelukast/day.

Subjects will receive one 5mg tablet of montelukast and 1 placebo tablet per day.

Subjects will receive two placebo tablets per day.

Eosinophilic Esophagitis

Those in Montelukast 10mg/day group will receive two 5mg tablets of Montelukast.

Montelukast

Those in the placebo group will receive 2 placebo tablets per day. Those in the Montelukast 5mg/day will receive 1 placebo tablet per day.

placebo

Subject will receive one 5mg tablet of Montelukast and one placebo tablet per day.

5 mg Montelukast

Children's Mercy Hospitals and Clinics

A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children

Eosinophils/hpf in the esophagus will be measured after 12 weeks of therapy.

Children's Mercy Hospital Kansas City

These patients will have echocardiography guided fluid management

Fluid management will be guided by monitoring of central venous pressure and urine output.

Peritoneal Neoplasms

Echocardiography Guided Fluid Management

Echocardiography will be utilized during the procedure to guide fluid management.

Echocardiogram

The Nebraska Medical Center

Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC

Comparison of Traditional (Central Venous Pressure (CVP) and Urine Output Guided) Versus Echocardiography Guided Fluid Management in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

The amount of fluid administered during the intraoperative period will be monitored and recorded. The outcome measure of interest is the difference between fluid given in the standard group vs the echo guided fluid management group.

esophageal stenosis/ödəm

A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children

Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC

Elm tərəfindən dəstəklənən ən tam dərman bitkiləri bazası